Adjuvant PD-1-based therapies for high-risk resected melanomas are here to stay.

Am J Surg

Department of Surgery, Division of Surgical Oncology, The Ohio State University College of Medicine, Columbus, OH, 43210, USA.

Published: September 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2024.115791DOI Listing

Publication Analysis

Top Keywords

adjuvant pd-1-based
4
pd-1-based therapies
4
therapies high-risk
4
high-risk resected
4
resected melanomas
4
melanomas stay
4
adjuvant
1
therapies
1
high-risk
1
resected
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!